(CNN) — The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and older, drugmaker Moderna said. “Flu remains a significant public health challenge, and mFLUSIVA provides an important new option for America’s seniors,” Moderna CEO Stephane Bancel said in a statement.
CNN Newsource offers unparalleled live, breaking and topical content.
With an unmatched newsgathering footprint and unrivaled client service,
we provide local news organizations with products and services
needed to outperform competition – across all platforms.
